Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lou Gehrigs Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02469896
What this trial is testing

A Trial of Tocilizumab in ALS Subjects

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig's Disease+1 more
Barrow Neurological Institute 22
Not applicableUnknownNCT05725759
What this trial is testing

Rehabilitation in SOD1 ALS Treated With Tofersen

Who this might be right for
Amyotrophic Lateral SclerosisLou Gehrig DiseaseFamilial Amyotrophic Lateral Sclerosis+2 more
Washington University School of Medicine 10
Not applicableNot Yet RecruitingNCT07341334
What this trial is testing

Digital Speech Markers for Monitoring ALS in Spanish Speakers

Who this might be right for
Amyotrophic Lateral SclerosisLou Gehrig's DiseaseALS
Nova Southeastern University 35
Testing effectiveness (Phase 2)UnknownNCT06315608
What this trial is testing

MRG-001 in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisLou Gehrig DiseaseMotor Neuron Disease+1 more
MedRegen LLC 10
Testing effectiveness (Phase 2)Looking for participantsNCT07142291
What this trial is testing

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
PhenoNet, Inc. 105
Large-scale testing (Phase 3)Study completedNCT05740813
What this trial is testing

HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 310
Large-scale testing (Phase 3)Study completedNCT04436497
What this trial is testing

HEALEY ALS Platform Trial - Regimen A Zilucoplan

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 162
Testing effectiveness (Phase 2)Study completedNCT00748501
What this trial is testing

Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Sangamo Therapeutics 45
Large-scale testing (Phase 3)Ended earlyNCT00818389
What this trial is testing

Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital 84
Testing effectiveness (Phase 2)Study completedNCT00931944
What this trial is testing

Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 74
Large-scale testing (Phase 3)Study completedNCT04414345
What this trial is testing

HEALEY ALS Platform Trial - Regimen C CNM-Au8

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 161
Not applicableLooking for participantsNCT05067179
What this trial is testing

Analysis of Human ALS Tissues and Registry of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Illinois at Chicago 40
Not applicableStudy completedNCT00821132
What this trial is testing

Genetics of Familial and Sporadic ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Familial Amyotrophic Lateral SclerosisALS With Frontotemporal Dementia (ALS/FTD)+4 more
Northwestern University 13,521
Not applicableStudy completedNCT00809224
What this trial is testing

Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALSAmyotrophic Lateral Sclerosis
University of Michigan 92
Large-scale testing (Phase 3)Study completedNCT04615923
What this trial is testing

HEALEY ALS Platform Trial - Regimen D Pridopidine

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 163
Testing effectiveness (Phase 2)Study completedNCT00790582
What this trial is testing

A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Forbes Norris MDA/ALS Research Center 109
Large-scale testing (Phase 3)Study completedNCT00444613
What this trial is testing

A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Eisai Co., Ltd. 373
Not applicableNo Longer AvailableNCT03537807
What this trial is testing

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT00125203
What this trial is testing

Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisSialorrhea
The University of Texas Health Science Center at San Antonio 20
Not applicableWithdrawnNCT01459302
What this trial is testing

Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaPLS+7 more
University of Massachusetts, Worcester
Next Page